anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
BACKGROUND: Klebsiella pneumoniae (KP), responsible for acute lung injury (ALI) and inflammation of the gastrointestinal tract, is a zoonotic pathogen that poses a threat to livestock farming worldwide. Nevertheless, there is currently no validated vaccine to prevent KP infection. The development of mucosal vaccines against KP using Lactobacillus plantarum (L. plantarum) is an effective strategy.
RESULTS: Firstly, the L. plantarum strains NC8-pSIP409-aCD11c' and NC8-pLc23-aCD11c were constructed via homologous recombination to express the aCD11c protein either inducibly or constitutively. Both NC8-pSIP409-aCD11c' and NC8-pLc23-aCD11c strains could enhance the adhesion and invasion of L. plantarum on bone marrow-derived dendritic cells (BMDCs), and stimulate the activation of BMDCs compared to the control strain NC8-pSIP409 in vitro. Following oral immunization of mice with NC8-pSIP409-aCD11c' and NC8-pLc23-aCD11c, the cellular, humoral, and mucosal immunity were significantly improved, as evidenced by the increased expression of CD4+ IL-4+ T cells in the spleen, IgG in serum, and secretory IgA (sIgA) in the intestinal lavage fluid (ILF). Furthermore, the protective effects of L. plantarum against inflammatory damage caused by KP infection were confirmed by assessing the bacterial loads in various tissues, lung wet/dry ratio (W/D), levels of inflammatory cytokines, and histological evaluation, which influenced T helper 17 (Th17) and regulatory T (Treg) cells in peripheral blood and lung.
CONCLUSIONS: Both the inducible and constitutive L. plantarum strains NC8-pSIP409-aCD11c' and NC8-pLc23-aCD11c have been found to stimulate cellular and humoral immunity levels and alleviate the inflammatory response caused by KP infection. These findings have provided a basis for the development of a novel vaccine against KP.
This randomised, crossover, sham-controlled study explored the neural basis of source-monitoring, a crucial cognitive process implicated in schizophrenia. Left superior temporal gyrus (STG) and dorsolateral prefrontal cortex (DLPFC) were the key focus areas. Thirty participants without neurological or psychological disorders underwent offline sham and active tDCS sessions with specific electrode montage targeting the left STG and DLPFC. Source-monitoring tasks, reality monitoring (Hear-Imagine), internal source-monitoring (Say-Imagine), and external source monitoring (Virtual-Real) were administered. Paired t-test and estimation statistics was performed with Graphpad version 10.1.0. The Benjamini-Hochberg procedure was employed to control the false discovery rate in multiple hypothesis testing. A significant improvement in internal source monitoring tasks (p = 0.001, Cohen's d = 0.97) was observed, but reality monitoring tasks demonstrated moderate improvement (p = 0.02, Cohen's d = 0.44). The study provides insights into the neural mechanisms of source monitoring in healthy individuals and proposes tDCS as a therapeutic intervention, laying the foundation for future studies to refine tDCS protocols and develop individualized approaches to address source monitoring deficits in schizophrenia.
Study subjects will be given 200mcg of TRH as a single intravenous (IV) bolus in endocrine clinic on Day 1 and Day 5. LT3 will be administered orally, twice a day (12 hours apart i.e. 8 AM and 8 PM) at a dosage of 10 mcg on Day 2-4. Levothyroxine will be taken after the TRH stimulation tests on Day 1 and day 5. Levothyroxine will be taken on Days 2-4 of the study. \*Patients will take their own LT4 that they are prescribed by their endocrinologist. The dose of Levothyroxine is titrated for each patient.
The utility model discloses a health care device used in various clothes and quilts belonging to personal daily products domain, which involves a health care device used in various clothes and quilts. The health care device includes a main part and magnetic part. Sockets are in the main part regularly. Magnets and medicine are in the sockets. Recessed groove in the main part. The electric wires are in the recessed groove. Activated carbon can be put in the sockets as well. The medicine can be aromatic medicine or blood activating medicine. This device can be put into any clothes and quilts and has the functions of magnetic therapy, medicine therapy and warming. The effects of eliminating various peculiar smells, stimulating blood circulation, neurasthenia prevention and treatment and bringing good mood for people are achieved. What is more, the device is of simple structure, convenience, durability, low cost and wide application for various people.
OBJECTIVES: This study explores whether textural features from initial non-contrast CT scans of infarcted brain tissue are linked to hemorrhagic transformation susceptibility.
MATERIALS AND METHODS: Stroke patients undergoing thrombolysis or thrombectomy from Jan 2012 to Jan 2022 were analyzed retrospectively. Hemorrhagic transformation was defined using follow-up magnetic resonance imaging. A total of 94 radiomic features were extracted from the infarcted tissue on initial NCCT scans. Patients were divided into training and test sets (7:3 ratio). Two models were developed with fivefold cross-validation: one incorporating first-order and textural radiomic features, and another using only textural radiomic features. A clinical model was also constructed using logistic regression with clinical variables, and test set validation was performed.
RESULTS: Among 362 patients, 218 had hemorrhagic transformations. The LightGBM model with all radiomics features had the best performance, with an area under the receiver operating characteristic curve (AUROC) of 0.986 (95% confidence interval [CI], 0.971-1.000) on the test dataset. The ExtraTrees model performed best when textural features were employed, with an AUROC of 0.845 (95% CI, 0.774-0.916). Minimum, maximum, and ten percentile values were significant predictors of hemorrhagic transformation. The clinical model showed an AUROC of 0.544 (95% CI, 0.431-0.658). The performance of the radiomics models was significantly better than that of the clinical model on the test dataset (p < 0.001).
CONCLUSIONS: The radiomics model can predict hemorrhagic transformation using NCCT in stroke patients. Low Hounsfield unit was a strong predictor of hemorrhagic transformation, while textural features alone can predict hemorrhagic transformation.
CLINICAL RELEVANCE STATEMENT: Using radiomic features extracted from initial non-contrast computed tomography, early prediction of hemorrhagic transformation has the potential to improve patient care and outcomes by aiding in personalized treatment decision-making and early identification of at-risk patients.
KEY POINTS: • Predicting hemorrhagic transformation following thrombolysis in stroke is challenging since multiple factors are associated. • Radiomics features of infarcted tissue on initial non-contrast CT are associated with hemorrhagic transformation. • Textural features on non-contrast CT are associated with the frailty of the infarcted tissue.
PROBLEM TO BE SOLVED: To enhance antimicrobial activities of an antibiotic substance against methicillin-resistant Staphylococcus aureus (MRSA) by adding tea catechins and/or theaflavins to the antibiotic substance. SOLUTION: Tea catechins containing epigallocatechin gallate as a principal ingredient and/or theaflavins containing theaflavin digallate as a principal ingredient are added to an antibiotic substance such as a β-lactam-based or an aminoglycoside-based antibiotic substance (e.g. oxacillin or methicillin) without manifesting antimicrobial and germicidal actions on MRSA alone. The antibiotic substance is used in an amount of 2-35μg/ml and the tea catechins are used in an amount of 5-120μg/ml. The theaflavins are used in an amount of 5-100μg/ml. The antimicrobial actions of the respective antibiotic substances manifested in the presence of 100μg/ml tea catechins are 5μg/ml oxacillin, 12.5μg/ml methicillin, 32μg/ml aminobenzylpenicilin, 2.5μg/ml tetracycline and 12.5μg/ml chloramphenicol.  The blending amounts of the tea catechins and theaflavins are preferably suitably determined by using the above data as a measure.
Preterm Infant is defined as a group of patients whose gestational age is lower than 37 weeks due to either iatrogenic reasons or maternal reasons. Preterm infant could be classified into 4 group according to gestational age: very early preterm infant, early preterm infant, midterm preterm infant, and late preterm infant. Moreover, they could be categorized into 3 groups of birth weight: extremely low birth weight, very low birth weight, and low birth weight. These varies of preterm infant are indicated to have further developmental and body-functional difficulties and lags. Under the basis of International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY) framework, problems related to Preterm infant would further limit their activities of daily living (ADL), participation, and health related quality of life (HRQOL).

The three fundamental goals of early rehabilitation for preterm infant after leaving NICU are: optimizing function within each child's prognostic potential, preventing the development of secondary conditions that impact life-long health, and promoting children's participation and qualities in their lives. Understanding knowledges of these developmental patterns of Function and Participation in Life Activities (FPLA) and HRQOL may be helpful for anticipating and managing the problems. This study hypothesizes that the course of developmental patterns in FPLA and HRQOL of preterm infant evolve with their age. The functional recovery levels include developmental function, health, activity, participation, and quality of life (QOL).

Since the previous plan only passed one year and encountered the COVID-19, the number of cases was not as expected. Therefore, this study will use the previous plan to test the functions of reliability, validity, and the evaluation of daily life participation to investigate the long-term performance of premature infants. Vertical development model under tracking. In addition, it is also expected to identify predictors related to the prognosis of preterm infants and compared with the healthy children of the Taiwan Early Childhood Development Survey Database (KIT) to find out the key differences in the developmental function and health of premature infants and healthy children. This study is a three-year longitudinal study of premature infants. It was carried out for three years. 60 full-term children aged 0-3 years and 150 premature infants aged 0-3 years were collected. A total of 210 children underwent a three-year period study. During the follow-up period, in addition to the initial evaluation, each subject will be followed up at 3 months, 6 months, 12 months, 18 months, and 24 months, toddlers( \>24months) will be followed up once a year according to the age of KIT's admission, and we will provide caregiver assessment report. We believe the results of this study will improve and support services provided to preterm infants.
Patients received magnesium sulfate (MgSO4 group, 150 mg in 4 mL of normal saline)delivered via aerosol mask at 10 L/min driven by pressurised air. Simultaneously, additional magnesium sulfate is given as an intravenous bolus (1.5g in 10 ml). Patients received thereafter 4 doses of nebulized magnesium sulfate with terbutaline at 30 min intervals.
Recurrent event data, which represent the occurrence of repeated incidences, are common in observational studies. Furthermore, collecting possible spatial correlations in health and environmental data is likely to provide more information for risk prediction. This article proposes a comprehensive proportional intensity model considering spatial random effects for recurrent event data using a Bayesian approach. The spatial information for areal data (where the spatial location is known up to a geographic unit such as a county) and georeferenced data (where the location is exactly observed) is examined. A traditional constant baseline intensity function, as well as a flexible piecewise constant baseline intensity function, are both under consideration. To estimate the parameters, a Markov chain Monte Carlo method with the Metropolis-Hastings algorithm and the adaptive Metropolis algorithm are applied. To assess the performance of model fitting, the deviance information criterion and log pseudo marginal likelihood are proposed. Overall, simulation studies demonstrate that the proposed model is significantly better than models that do not consider spatial effects if spatial correlations exist. Finally, our approach is implemented using a dataset related to the recurrence of cardiovascular diseases, which incorporates spatial information.
The invention discloses a compound preparation of lumbrukinase and clopidogrel, and a preparation method thereof. The compound preparation comprises A) a lumbrukinase enteric-coated preparation prepared from lumbrukinase, pharmaceutically acceptable adjuvant thereof and an enteric coating material, and B) a clopidogrel preparation prepared from clopidogrel or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable adjuvant thereof. In the compound preparation, a ratio of lumbrukinase to clopidogrel or the pharmaceutically acceptable salt thereof is 0.1-2 million U: 10-15 mg. The dosage form of the compound preparation may be a capsule or a tablet. The contents of the capsule is a mixture of the lumbrukinase enteric-coated preparation and the clopidogrel preparation, wherein the lumbrukinase enteric-coated preparation may be a granule, mixed powder, pellet, tablet or capsule, the clopidogrel preparation may be a granule, mixed powder, pellet or tablet, and the capsule shell of the capsule is a gastric-coated hollow capsule. The tablet is obtained after tableting of the lumbrukinase enteric-coated preparation and the clopidogrel preparation, wherein the lumbrukinase enteric-coated preparation or clopidogrel preparation may be a granule, mixed powder or pellet. The compound preparation provided by the invention can improve compliance of patients in administration.
The invention discloses external applied heat-reducing medicinal liquor, which is prepared by soaking 10 to 40 grams of jasmine, 5 to 30 grams of scutellaria baicalensis, 3 to 10 grams of as arum, 1 to 6 grams of menthol and 1 to 6 grams of borneol in white liquor or alcohol. The external applied heat-reducing medicinal liquor has the effects of clearing heat, detoxifying, cooling blood, relieving restlessness and relieving cough and pain, and has functions of clearing heat, resisting inflammation, resisting viruses, relieving pain and itching and relieving allergy and can be used for treating heat and fever caused by various of reasons, particularly heat, fever, cough and headache caused by infection of the upper respiratory tract, pneumonia, cold, sphagitis, tonsillitis, mumps and acute bronchitis. The external applied heat-reducing medicinal liquor also can be used for treating protopathy and is particularly suitable for treating high fever and convulsion in infants, children. The external applied heat-reducing medicinal liquor can increase immunity and resistance. The external applied heat-reducing medicinal liquor also can be used for treating closed soft tissue injury, acute mastitis, acute gouty arthritis, herpes zoster and burn and scalding. The external applied heat-reducing medicinal liquor can be accepted easily and address both the symptoms and root causes, and is convenient to use and quick in effectiveness.
An NCI goal is to identify every human gene that predisposes people to cancer. Recent studies of HIV -1 indicate that genetic polymorphisms can affect susceptibility to viral infections and that such alleles may be detected in studies of small numbers of highly exposed-uninfected subjects. Because such alleles may be racially restricted, a range of racial and ethnic groups should be included in such studies. We propose to examine genetic determinants of infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in an ethnically diverse population of injection drug users (lDUs). HBV and HCV are important causes of hepatocellular carcinoma, but little is known about genetic factors that alter susceptibility to these infections. Subjects will be recruited in diverse inner-city neighborhoods as part of the University of California, San Francisco's Urban Health Study. Since 1986, this study has successfully recruited and evaluated IDUs from street-based settings. About half of the participants are African-American, one-third are white, 10% are Latino, and the remainder are Asian or Native American. The mean duration of drug use exceeds 20 years. About 80% of subjects have evidence of HBV infection and a similar prevalence of HCV infection is anticipated. We will enroll about 1500 subjects over a 13 month period. Archived, unlinked serum specimens may obtained from previous enrollees to increase the sample size, as needed. Highly exposed-uninfected subjects will be ascertained on the basis of the serologic testing for each virus, as well as the duration and frequency of injection drug use. These highly exposed-uninfected subjects will be compared to infected subjects with regard to their frequency of genetic polymorphisms (chemokines, chemokine receptors, human leukocyte antigens, and others), in collaboration with scientists from NCI's Laboratory of Genomic Diversity.
There is only 1 arm. Combination therapy arm included venetoclax combined with hypomethylating agents such as azacitidine or decitabine. 1. venetoclax: 400mg/d, po, days 1-7 of each 28-day cycle. 2.For patients without TP53 mutation, azacitidine was administered: 32mg/m2/d, ih, days 1-5 of each 28-day cycle; for patients with TP53 mutation, decitabine was administered: 5mg/m2/d, iv, days 1-5 of each 28-day cycle.
Infants randomized to the morphine arm will start at a dose of 0.06 mg/kg/dose every 4 hours. A buprenorphine placebo will also be given at the same frequency as a faux drug.
FIELD: medicine, pharmacy. SUBSTANCE: invention relates to agent used for correction of hemostasis. Invention proposes quinoline derivatives, a pharmaceutical composition and their using. Invention provides the expressed biological activity and one of their in the level of hirudin as one of the most active and expensive imported drugs. Coagulating and anticoagulating activity of these substances is associated with their effect on the function of system thrombin/thrombin receptors that provides originality (quality) of agents. EFFECT: enhanced effectiveness of agent, valuable medicinal properties. 4 cl, 2 tbl, 9 ex
The patient will be put on virtual reality glasses five minutes before the chest tube is removed. Afterwards, it will continue to be watched while the tube is taken and virtual reality glasses will be watched for another five minutes. Pain level and hemodynamic variables will be checked before, during, and 15 and 30 minutes after virtual reality glasses are watched. The participants in the control group will receive routine treatment and care, and their data will be collected at the same time as those in the study group. Hemodynamic variables will be monitored and recorded on the monitor.

Virtual reality glasses application is a method without any side effects. During the research, any adverse condition (vision problem, nausea, dizziness, etc.) related to the use of virtual glasses will be observed by the researcher. Since virtual reality glasses will be used in another patient after being used on one patient, disinfection will be made in line with the company's recommendations, taking into account the pandemic conditions. Throughout the application, feedback will be received from the patients by the researchers.
PURPOSE: A liposome containing phospholipid and an acetylene group is provided to manufacture a sensor with enhanced sensitivity and to sensitively detect a target material in a sample. CONSTITUTION: A liposome containing an acetylene group comprises lipid bilayer containing first and second lipid molecules. The first lipid molecule is a diacetylene molecule with an epoxy group at the end. The second lipid molecule is diacyl glycerol-3-phosphate molecule. The diacetylene molecule has a structure of formula I. The diacyl glycerol-3-phosphate molecule is 1,2-dimyristoyl-sn-glycero-3-phosphate (DMPA). A method for detecting a target material in a sample comprises the steps of: contacting a target material-binding material with the target material in the sample; detecting an optical signal; and identifying the target material from the optical signal.
Corticosteroids inhibit the inflammatory response to a variety of inciting agents and probably delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation associated with inflammation. There is no generally accepted explanation for the mechanism of action of ocular corticosteroids. However, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. Corticosteroids are capable of producing a rise in intraocular pressure (IOP).

Loteprednol etabonate is structurally similar to other corticosteroids. However, the number 20 position ketone group is absent. It is highly lipid soluble which enhances its penetration into cells. Loteprednol etabonate is synthesized through structural modifications of prednisolone-related compounds so that it will undergo a predictable transformation to an inactive metabolite. Based upon in vivo and in vitro preclinical metabolism studies, loteprednol etabonate undergoes extensive metabolism to inactive carboxylic acid metabolites.

Results from a bioavailability study in normal volunteers established that plasma levels of loteprednol etabonate and Δ1 cortienic acid etabonate (PJ 91), its primary, inactive metabolite, were below the limit of quantitation (1 ng/mL) at all sampling times. The results were obtained following the ocular administration of one drop in each eye of 0.5% loteprednol etabonate 8 times daily for 2 days or 4 times daily for 42 days. This study suggests that limited (<1 ng/mL) systemic absorption occurs with loteprednol etabonate.
Patients receive multivitamins orally once daily for 3 years. Patients are followed every 3 months for 2 years, then every 6 months for 1 year, and then annually thereafter.
Atraumatic restorative technique will be performed. Then the cavities will be dried with a gentle flow of compressed air. One drop of silver diamine fluoride (Advantage Arrest Silver Diamine Fluoride 38% - Bottle) will be dispensed into a dappen dish. A micro brush will be bent, dipped into SDF and dabbed on the side of the dappen dish to remove excess liquid before application. SDF will be applied directly to affected tooth surface and dried with gentle flow of compressed air for 1 minute. Excess SDF will be removed with cotton roll. Teeth will be restored with glass ionomer cement (GC Fuji IX).